U.S. Physical Therapy Management
Management criteria checks 4/4
U.S. Physical Therapy's CEO is Chris Reading, appointed in Nov 2004, has a tenure of 20.5 years. total yearly compensation is $3.64M, comprised of 26.8% salary and 73.2% bonuses, including company stock and options. directly owns 0.76% of the company’s shares, worth $8.97M. The average tenure of the management team and the board of directors is 5.8 years and 12.3 years respectively.
Key information
Chris Reading
Chief executive officer
US$3.6m
Total compensation
| CEO salary percentage | 26.79% |
| CEO tenure | 20.5yrs |
| CEO ownership | 0.8% |
| Management average tenure | 5.8yrs |
| Board average tenure | 12.3yrs |
Recent management updates
Recent updates
Here's Why It's Unlikely That U.S. Physical Therapy, Inc.'s (NYSE:USPH) CEO Will See A Pay Rise This Year
May 14
Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?
Mar 24U.S. Physical Therapy, Inc. Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next
Mar 01U.S. Physical Therapy (NYSE:USPH) Seems To Use Debt Quite Sensibly
Feb 28Capital Allocation Trends At U.S. Physical Therapy (NYSE:USPH) Aren't Ideal
Jan 03Shareholders Should Be Pleased With U.S. Physical Therapy, Inc.'s (NYSE:USPH) Price
Nov 09
Tactical Contract Renegotiations And Innovative Recruitment Tactics Propel Revenue Growth And Margin Expansion
Innovations in recruitment and operational efficiencies are set to bolster net margins despite a tight labor market and high costs.U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively
Aug 07U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet
Jul 17U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't
Jun 04There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings
May 21U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44
May 11Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)
May 05A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)
Apr 21Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?
Apr 07U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit
Mar 04The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence
Dec 23Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching
Dec 07U.S. Physical Therapy: Positioned For Market Dominance Amidst Attractive Valuations
Oct 13Is U.S. Physical Therapy (NYSE:USPH) A Risky Investment?
Oct 13U.S. Physical Therapy (NYSE:USPH) Could Be Struggling To Allocate Capital
Sep 05Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?
Aug 15Are U.S. Physical Therapy, Inc. (NYSE:USPH) Investors Paying Above The Intrinsic Value?
Aug 01U.S. Physical Therapy: Bolt-On Strategy Scaling Earnings Power (Rating Upgrade)
Jul 19At US$114, Is U.S. Physical Therapy, Inc. (NYSE:USPH) Worth Looking At Closely?
May 07U.S. Physical Therapy, Inc.'s (NYSE:USPH) Intrinsic Value Is Potentially 25% Below Its Share Price
Apr 16U.S. Physical Therapy (NYSE:USPH) Has A Pretty Healthy Balance Sheet
Apr 01Some Investors May Be Worried About U.S. Physical Therapy's (NYSE:USPH) Returns On Capital
Mar 04U.S. Physical Therapy beats Q4 top and bottom line estimates; initiates FY23 outlook
Feb 23U.S. Physical Therapy: Needs To Illustrate Economic Reality Over Accounting Profit
Feb 12Is Now An Opportune Moment To Examine U.S. Physical Therapy, Inc. (NYSE:USPH)?
Jan 24We Think U.S. Physical Therapy (NYSE:USPH) Can Stay On Top Of Its Debt
Dec 20CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2025 | n/a | n/a | US$33m |
| Dec 31 2024 | US$4m | US$974k | US$28m |
| Sep 30 2024 | n/a | n/a | US$14m |
| Jun 30 2024 | n/a | n/a | US$16m |
| Mar 31 2024 | n/a | n/a | US$18m |
| Dec 31 2023 | US$3m | US$959k | US$18m |
| Sep 30 2023 | n/a | n/a | US$24m |
| Jun 30 2023 | n/a | n/a | US$26m |
| Mar 31 2023 | n/a | n/a | US$28m |
| Dec 31 2022 | US$2m | US$926k | US$29m |
| Sep 30 2022 | n/a | n/a | US$39m |
| Jun 30 2022 | n/a | n/a | US$38m |
| Mar 31 2022 | n/a | n/a | US$37m |
| Dec 31 2021 | US$4m | US$896k | US$31m |
| Sep 30 2021 | n/a | n/a | US$31m |
| Jun 30 2021 | n/a | n/a | US$30m |
| Mar 31 2021 | n/a | n/a | US$32m |
| Dec 31 2020 | US$3m | US$676k | US$32m |
| Sep 30 2020 | n/a | n/a | US$30m |
| Jun 30 2020 | n/a | n/a | US$31m |
| Mar 31 2020 | n/a | n/a | US$29m |
| Dec 31 2019 | US$3m | US$769k | US$31m |
| Sep 30 2019 | n/a | n/a | US$30m |
| Jun 30 2019 | n/a | n/a | US$23m |
| Mar 31 2019 | n/a | n/a | US$18m |
| Dec 31 2018 | US$3m | US$739k | US$17m |
Compensation vs Market: Chris's total compensation ($USD3.64M) is about average for companies of similar size in the US market ($USD3.99M).
Compensation vs Earnings: Chris's compensation has been consistent with company performance over the past year.
CEO
Chris Reading (60 yo)
Mr. Christopher J. Reading, also known as Chris, has been the Chief Executive Officer of US Physical Therapy Inc. since November 1, 2004 and serves as its Chairman since May 21, 2024 and served as its Pres...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman | 20.5yrs | US$3.64m | 0.76% $ 9.0m | |
| President & COO | 1yr | US$2.26m | 0.18% $ 2.1m | |
| Chief Financial Officer | 4.5yrs | US$1.63m | 0.19% $ 2.2m | |
| Executive VP | 14.3yrs | US$1.49m | 0.13% $ 1.5m | |
| Chief Operating Officer - West | 7.2yrs | US$1.85m | 0.17% $ 2.0m | |
| Senior Vice President of Finance & Accounting | 3.1yrs | no data | no data | |
| Senior Vice President of Information Systems | no data | no data | no data | |
| Senior VP & Chief Compliance Officer | no data | no data | no data | |
| Vice President of Human Resources | no data | no data | no data |
Experienced Management: USPH's management team is seasoned and experienced (5.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman | 20.5yrs | US$3.64m | 0.76% $ 9.0m | |
| Independent Director | 2yrs | US$215.09k | 0.0073% $ 85.9k | |
| Independent Director | 20.3yrs | US$245.09k | 0.042% $ 496.5k | |
| Lead Independent Director | 19.8yrs | US$256.97k | 0.11% $ 1.3m | |
| Independent Director | 7yrs | US$235.09k | 0.12% $ 1.5m | |
| Independent Director | 17.7yrs | US$225.09k | 0.12% $ 1.5m | |
| Independent Director | 3.3yrs | US$215.09k | 0.012% $ 135.2k | |
| Director | less than a year | no data | 0.12% $ 1.4m |
Experienced Board: USPH's board of directors are seasoned and experienced ( 12.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/22 23:13 |
| End of Day Share Price | 2025/05/22 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
U.S. Physical Therapy, Inc. is covered by 14 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Petusky | Barrington Research Associates, Inc. |
| Joanna Sylvia Gajuk | BofA Global Research |
| null null | Burkenroad Reports |